The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.
Olivennes
F
F
Department of Obstetrics and Gynecology, Hopital Cochin, Paris, France. olivennes@cch.ap-hop-paris.fr
D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000819:agonists / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D006727:Hormone Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007986:Luteinizing Hormone / Q000187:drug effects / Q000378:metabolism; D008597:Menstrual Cycle / Q000187:drug effects; D009865:Oocytes / Q000187:drug effects; D010062:Ovulation Induction; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy / Q000503:physiopathology; D011247:Pregnancy; D018873:Pregnancy Rate
D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; C061018:ganirelix; C062876:cetrorelix